Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance

 Abstract

Maternal-fetal cellular trafficking during pregnancy results in bidirectional microchimerism with potentially long-term consequences for the mother and her fetus. Exposure of the fetus to maternal cells results in tolerance to non-inherited maternal antigens (NIMA) and may therefore impact transplant outcomes. We investigated the rates of graft failure and retransplantation after parental liver transplantation in pediatric recipients with biliary atresia (BA), a disease with high levels of maternal microchimerism. We observed significantly lower rates of graft failure and retransplantation in BA recipients of maternal livers compared with BA recipients of paternal livers. Importantly, recipients without BA had equivalent transplant outcomes with maternal and paternal organs, suggesting that increased maternal microchimerism in BA patients may be the underlying etiology for tolerance. These results support the concept that prenatal exposure to NIMA may have consequences for living-related organ transplantation.

 Article Addendum to:

A Nijagal, S Fleck, NK Hills, S Feng, Q Tang, SM Kang, et al. Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia. Am J Transplant 2012; 12: 409- 19.
PMID: 22221561 DOI: 10.1111/j.1600-6143.2011.03895.x

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
37 - 39
doi
10.4161/chim.20152
Type
Article Addendum
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Maternal microchimerism in patients with biliary atresia: Implications for allograft tolerance